SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-23-222073
Filing Date
2023-08-28
Accepted
2023-08-28 07:38:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 425 d540669d425.htm 425 15247
  Complete submission text file 0001193125-23-222073.txt   16820
Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Filed by) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Subject) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40384 | Film No.: 231210178
SIC: 2836 Biological Products, (No Diagnostic Substances)